Filing Details

Accession Number:
0001209191-11-019597
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-24 19:58:18
Reporting Period:
2011-03-23
Filing Date:
2011-03-24
Accepted Time:
2011-03-24 19:58:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1292162 Bryant Steven Porter 3280 Bayshore Boulevard
Brisbane CA 94005
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-23 8,969 $15.40 66,698 No 4 M Direct
Common Stock Disposition 2011-03-23 8,969 $43.39 57,729 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-03-23 8,969 $0.00 8,969 $15.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-06-30 No 4 M Direct
Footnotes
  1. These transactions were made pursuant to a 10b5-1 trading plan entered into in the fourth quarter of 2010 and in effect at the time of the transactions. The transactions were pre-determined in the trading plan to occur at specific dates and share prices of InterMune.
  2. Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $43.03 to $43.91 per share. Full information on the numbers of shares sold at each sale price is available upon request.
  3. Fully exercisable.